3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Multiple Myeloma
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Smoking Cessation
1
Quality of Life
1
Postoperative Complications
1
Patient Compliance
1
Neoplasms
1
Metabolic Syndrome
1
Localized Prostate Carcinoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypothalamic Neoplasms
1
Healthy Diet
1
Glioma
1
Gastrointestinal Neoplasms
1
Interventions
Fluorouracil
9
Oxaliplatin
7
Leucovorin
7
Surveys and Questionnaires
6
Blood Specimen Collection
6
Bevacizumab
6
Specimen Handling
5
Gemcitabine
5
Cetuximab
5
Capecitabine
5
fludarabine
4
aldesleukin
4
Standard of Care
4
Irinotecan
4
Cyclophosphamide
4
Remote Patient Monitoring
3
Radiosurgery
3
Pafolacianine
3
Nivolumab
3
Endoscopic Mucosal Resection
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
encorafenib
2
Tomography, X-Ray Computed
2
Sunitinib
2
Referral and Consultation
2
Radiotherapy
2
Practice Guidelines as Topic
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Diet Therapy
×
1 year
×
Clear all
NCT05441163
2025-06-24
ProActIF-01
Institut Curie
Phase NA
Recruiting
50 enrolled